Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹40 Cr₹31 Cr₹6,052,481 Cr₹52 Cr₹14 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹40 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹40 Cr
Mar2024₹31 Cr
Mar2023₹6,052,481 Cr
Mar2022₹52 Cr
Mar2021₹14 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2025 ₹40 Cr
27.93
Mar2024 ₹31 Cr
-100.00
Mar2023 ₹6,052,481 Cr
11,633,245.46
Mar2022 ₹52 Cr
279.32
Mar2021 ₹14 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹226.1 Cr 4.6% 13.2% -25.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,559.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹164,827.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,942.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹106,825.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,077.0 Cr -3.4% -5.7% 0.3% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

4.6%

13.2%

-25.2%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses